GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Savior Lifetec Corp (ROCO:4167) » Definitions » Gross-Profit-to-Asset %

Savior Lifetec (ROCO:4167) Gross-Profit-to-Asset % : 9.03% (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Savior Lifetec Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Savior Lifetec's annualized Gross Profit for the quarter that ended in Mar. 2025 was NT$389 Mil. Savior Lifetec's average Total Assets over the quarter that ended in Mar. 2025 was NT$4,310 Mil. Therefore, Savior Lifetec's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 was 9.03%.


Savior Lifetec Gross-Profit-to-Asset % Historical Data

The historical data trend for Savior Lifetec's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Savior Lifetec Gross-Profit-to-Asset % Chart

Savior Lifetec Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.60 6.57 2.93 5.37 8.46

Savior Lifetec Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.58 8.93 12.86 8.01 9.03

Competitive Comparison of Savior Lifetec's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Savior Lifetec's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Savior Lifetec's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Savior Lifetec's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Savior Lifetec's Gross-Profit-to-Asset % falls into.


;
;

Savior Lifetec Gross-Profit-to-Asset % Calculation

Savior Lifetec's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=346.756/( (3822.671+4376.12)/ 2 )
=346.756/4099.3955
=8.46 %

Savior Lifetec's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=389.024/( (4376.12+4243.381)/ 2 )
=389.024/4309.7505
=9.03 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2025) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Savior Lifetec Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Savior Lifetec's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Savior Lifetec Business Description

Traded in Other Exchanges
N/A
Address
No. 29, Kezhong Road, Hsinchu Science Park, Zhunan Township, Miaoli, TWN, 350
Savior Lifetec Corp is engaged in the research, development, design, manufacture, and sale of carbapenem generics, injection generics, controlled-release generics, development of new dosage forms and drugs, and the APIs, excipients, intermediates, and dosage forms of the aforementioned products. The company also provides medicine manufacturer technology and services. The company geographically operates in four regions such as the Americas, Asia, Taiwan, and Europe.

Savior Lifetec Headlines

No Headlines